Doctors seek safer dose for Infants' Wake-Up drug
NCT ID NCT07477132
Summary
This study aims to find the correct dose of a drug called sugammadex for infants under 2 years old. Sugammadex is given after surgery to quickly reverse the effects of a muscle-paralyzing drug, helping babies wake up and breathe on their own. Researchers will test different doses in 99 infants to see what works best and is safest for different age groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CURARIZATION, POSTOPERATIVE RESIDUAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier universitaire Caen Normandie
Caen, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.